nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenofibrate—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.166	0.25	CbGbCtD
Fenofibrate—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.116	0.175	CbGbCtD
Fenofibrate—CYP2C8—Progesterone—uterine cancer	0.11	0.166	CbGbCtD
Fenofibrate—CYP2C9—Progesterone—uterine cancer	0.0768	0.116	CbGbCtD
Fenofibrate—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0674	0.102	CbGbCtD
Fenofibrate—CYP2C8—Etoposide—uterine cancer	0.0493	0.0742	CbGbCtD
Fenofibrate—CYP3A4—Progesterone—uterine cancer	0.0447	0.0672	CbGbCtD
Fenofibrate—CYP3A4—Etoposide—uterine cancer	0.02	0.0301	CbGbCtD
Fenofibrate—CYP3A4—Doxorubicin—uterine cancer	0.0136	0.0205	CbGbCtD
Fenofibrate—Indomethacin—AKR1C3—uterine cancer	0.00361	0.625	CrCbGaD
Fenofibrate—Indomethacin—CXCL8—uterine cancer	0.00217	0.375	CrCbGaD
Fenofibrate—PPARA—Estrogen Receptor Pathway—ESR1—uterine cancer	0.000987	0.0537	CbGpPWpGaD
Fenofibrate—PPARA—Nuclear Receptors—PGR—uterine cancer	0.000784	0.0426	CbGpPWpGaD
Fenofibrate—PPARA—Nuclear Receptors—ESR2—uterine cancer	0.00069	0.0375	CbGpPWpGaD
Fenofibrate—PPARA—Nuclear Receptor transcription pathway—PGR—uterine cancer	0.000619	0.0337	CbGpPWpGaD
Fenofibrate—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—uterine cancer	0.000575	0.0313	CbGpPWpGaD
Fenofibrate—PPARA—Nuclear Receptor transcription pathway—ESR2—uterine cancer	0.000545	0.0297	CbGpPWpGaD
Fenofibrate—PPARA—epithelium—uterine cancer	0.000454	0.152	CbGeAlD
Fenofibrate—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—uterine cancer	0.000443	0.0241	CbGpPWpGaD
Fenofibrate—PPARA—smooth muscle tissue—uterine cancer	0.000437	0.147	CbGeAlD
Fenofibrate—PPARA—renal system—uterine cancer	0.000421	0.141	CbGeAlD
Fenofibrate—PPARA—Nuclear Receptors—ESR1—uterine cancer	0.000418	0.0228	CbGpPWpGaD
Fenofibrate—PPARA—Circadian rythm related genes—STAR—uterine cancer	0.000375	0.0204	CbGpPWpGaD
Fenofibrate—PPARA—REV-ERBA represses gene expression—EP300—uterine cancer	0.000361	0.0196	CbGpPWpGaD
Fenofibrate—PPARA—RORA activates circadian gene expression—EP300—uterine cancer	0.000349	0.019	CbGpPWpGaD
Fenofibrate—PPARA—female reproductive system—uterine cancer	0.000337	0.113	CbGeAlD
Fenofibrate—PPARA—Nuclear Receptor transcription pathway—ESR1—uterine cancer	0.000331	0.018	CbGpPWpGaD
Fenofibrate—PPARA—female gonad—uterine cancer	0.000307	0.103	CbGeAlD
Fenofibrate—PPARA—Circadian rythm related genes—HNF1B—uterine cancer	0.000306	0.0166	CbGpPWpGaD
Fenofibrate—PPARA—Adipogenesis—HMGA1—uterine cancer	0.000293	0.0159	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—PLXNA3—uterine cancer	0.000284	0.0154	CbGpPWpGaD
Fenofibrate—PPARA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—uterine cancer	0.000255	0.0139	CbGpPWpGaD
Fenofibrate—Malaise—Etoposide—uterine cancer	0.000244	0.00079	CcSEcCtD
Fenofibrate—Dermatitis bullous—Doxorubicin—uterine cancer	0.000244	0.000789	CcSEcCtD
Fenofibrate—Vertigo—Etoposide—uterine cancer	0.000243	0.000787	CcSEcCtD
Fenofibrate—Leukopenia—Etoposide—uterine cancer	0.000242	0.000784	CcSEcCtD
Fenofibrate—Body temperature increased—Dactinomycin—uterine cancer	0.000241	0.000781	CcSEcCtD
Fenofibrate—Abdominal pain—Dactinomycin—uterine cancer	0.000241	0.000781	CcSEcCtD
Fenofibrate—Hypoglycaemia—Doxorubicin—uterine cancer	0.000239	0.000773	CcSEcCtD
Fenofibrate—Cough—Etoposide—uterine cancer	0.000236	0.000765	CcSEcCtD
Fenofibrate—Blood creatinine increased—Epirubicin—uterine cancer	0.000236	0.000764	CcSEcCtD
Fenofibrate—Hypertension—Etoposide—uterine cancer	0.000234	0.000756	CcSEcCtD
Fenofibrate—Pain in extremity—Doxorubicin—uterine cancer	0.000233	0.000755	CcSEcCtD
Fenofibrate—Osteoarthritis—Doxorubicin—uterine cancer	0.000233	0.000755	CcSEcCtD
Fenofibrate—Liver function test abnormal—Epirubicin—uterine cancer	0.000232	0.000753	CcSEcCtD
Fenofibrate—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000232	0.000752	CcSEcCtD
Fenofibrate—Chest pain—Etoposide—uterine cancer	0.00023	0.000746	CcSEcCtD
Fenofibrate—Migraine—Doxorubicin—uterine cancer	0.000229	0.000743	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000229	0.000741	CcSEcCtD
Fenofibrate—Discomfort—Etoposide—uterine cancer	0.000228	0.000737	CcSEcCtD
Fenofibrate—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000227	0.000734	CcSEcCtD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000226	0.0123	CbGpPWpGaD
Fenofibrate—Nasopharyngitis—Epirubicin—uterine cancer	0.000225	0.000729	CcSEcCtD
Fenofibrate—Hypersensitivity—Dactinomycin—uterine cancer	0.000225	0.000728	CcSEcCtD
Fenofibrate—Gastritis—Epirubicin—uterine cancer	0.000223	0.000722	CcSEcCtD
Fenofibrate—Muscular weakness—Epirubicin—uterine cancer	0.000222	0.000719	CcSEcCtD
Fenofibrate—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000222	0.000719	CcSEcCtD
Fenofibrate—Infection—Etoposide—uterine cancer	0.000219	0.00071	CcSEcCtD
Fenofibrate—PPARA—Adipogenesis—SOCS3—uterine cancer	0.000219	0.0119	CbGpPWpGaD
Fenofibrate—Asthenia—Dactinomycin—uterine cancer	0.000219	0.000709	CcSEcCtD
Fenofibrate—Blood creatinine increased—Doxorubicin—uterine cancer	0.000218	0.000707	CcSEcCtD
Fenofibrate—Influenza—Epirubicin—uterine cancer	0.000218	0.000705	CcSEcCtD
Fenofibrate—Asthma—Epirubicin—uterine cancer	0.000218	0.000705	CcSEcCtD
Fenofibrate—Thrombocytopenia—Etoposide—uterine cancer	0.000216	0.0007	CcSEcCtD
Fenofibrate—Tachycardia—Etoposide—uterine cancer	0.000215	0.000698	CcSEcCtD
Fenofibrate—Eosinophilia—Epirubicin—uterine cancer	0.000215	0.000698	CcSEcCtD
Fenofibrate—Liver function test abnormal—Doxorubicin—uterine cancer	0.000215	0.000697	CcSEcCtD
Fenofibrate—Skin disorder—Etoposide—uterine cancer	0.000214	0.000695	CcSEcCtD
Fenofibrate—Hyperhidrosis—Etoposide—uterine cancer	0.000213	0.000691	CcSEcCtD
Fenofibrate—Pancreatitis—Epirubicin—uterine cancer	0.000213	0.000691	CcSEcCtD
Fenofibrate—Angina pectoris—Epirubicin—uterine cancer	0.000212	0.000687	CcSEcCtD
Fenofibrate—Anorexia—Etoposide—uterine cancer	0.00021	0.000682	CcSEcCtD
Fenofibrate—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.00021	0.000679	CcSEcCtD
Fenofibrate—CYP2C8—Arachidonic acid metabolism—AKR1C3—uterine cancer	0.000209	0.0114	CbGpPWpGaD
Fenofibrate—Bronchitis—Epirubicin—uterine cancer	0.000209	0.000678	CcSEcCtD
Fenofibrate—Diarrhoea—Dactinomycin—uterine cancer	0.000209	0.000676	CcSEcCtD
Fenofibrate—Nasopharyngitis—Doxorubicin—uterine cancer	0.000208	0.000675	CcSEcCtD
Fenofibrate—Hypotension—Etoposide—uterine cancer	0.000206	0.000668	CcSEcCtD
Fenofibrate—Gastritis—Doxorubicin—uterine cancer	0.000206	0.000668	CcSEcCtD
Fenofibrate—Muscular weakness—Doxorubicin—uterine cancer	0.000205	0.000665	CcSEcCtD
Fenofibrate—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000205	0.000665	CcSEcCtD
Fenofibrate—Dysuria—Epirubicin—uterine cancer	0.000203	0.000659	CcSEcCtD
Fenofibrate—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000202	0.000655	CcSEcCtD
Fenofibrate—Influenza—Doxorubicin—uterine cancer	0.000201	0.000652	CcSEcCtD
Fenofibrate—Asthma—Doxorubicin—uterine cancer	0.000201	0.000652	CcSEcCtD
Fenofibrate—Pollakiuria—Epirubicin—uterine cancer	0.000201	0.000651	CcSEcCtD
Fenofibrate—Eosinophilia—Doxorubicin—uterine cancer	0.000199	0.000646	CcSEcCtD
Fenofibrate—Photosensitivity reaction—Epirubicin—uterine cancer	0.000199	0.000643	CcSEcCtD
Fenofibrate—Paraesthesia—Etoposide—uterine cancer	0.000198	0.000642	CcSEcCtD
Fenofibrate—Weight increased—Epirubicin—uterine cancer	0.000198	0.000641	CcSEcCtD
Fenofibrate—Pancreatitis—Doxorubicin—uterine cancer	0.000197	0.000639	CcSEcCtD
Fenofibrate—PPARA—lymph node—uterine cancer	0.000197	0.0662	CbGeAlD
Fenofibrate—Weight decreased—Epirubicin—uterine cancer	0.000197	0.000638	CcSEcCtD
Fenofibrate—Dyspnoea—Etoposide—uterine cancer	0.000197	0.000637	CcSEcCtD
Fenofibrate—PPARA—Circadian rythm related genes—EZH2—uterine cancer	0.000196	0.0107	CbGpPWpGaD
Fenofibrate—Somnolence—Etoposide—uterine cancer	0.000196	0.000636	CcSEcCtD
Fenofibrate—Angina pectoris—Doxorubicin—uterine cancer	0.000196	0.000635	CcSEcCtD
Fenofibrate—Pneumonia—Epirubicin—uterine cancer	0.000195	0.000632	CcSEcCtD
Fenofibrate—Infestation—Epirubicin—uterine cancer	0.000194	0.000628	CcSEcCtD
Fenofibrate—Infestation NOS—Epirubicin—uterine cancer	0.000194	0.000628	CcSEcCtD
Fenofibrate—Vomiting—Dactinomycin—uterine cancer	0.000194	0.000628	CcSEcCtD
Fenofibrate—Bronchitis—Doxorubicin—uterine cancer	0.000194	0.000627	CcSEcCtD
Fenofibrate—Rash—Dactinomycin—uterine cancer	0.000192	0.000623	CcSEcCtD
Fenofibrate—Decreased appetite—Etoposide—uterine cancer	0.000192	0.000622	CcSEcCtD
Fenofibrate—PPARA—Adipogenesis—SMAD3—uterine cancer	0.000192	0.0104	CbGpPWpGaD
Fenofibrate—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000192	0.0104	CbGpPWpGaD
Fenofibrate—Renal failure—Epirubicin—uterine cancer	0.000191	0.000618	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Etoposide—uterine cancer	0.000191	0.000617	CcSEcCtD
Fenofibrate—Fatigue—Etoposide—uterine cancer	0.00019	0.000616	CcSEcCtD
Fenofibrate—Jaundice—Epirubicin—uterine cancer	0.000189	0.000613	CcSEcCtD
Fenofibrate—CYP2C8—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000189	0.0103	CbGpPWpGaD
Fenofibrate—Constipation—Etoposide—uterine cancer	0.000189	0.000611	CcSEcCtD
Fenofibrate—Pain—Etoposide—uterine cancer	0.000189	0.000611	CcSEcCtD
Fenofibrate—Conjunctivitis—Epirubicin—uterine cancer	0.000189	0.000611	CcSEcCtD
Fenofibrate—Urinary tract infection—Epirubicin—uterine cancer	0.000189	0.000611	CcSEcCtD
Fenofibrate—Dysuria—Doxorubicin—uterine cancer	0.000188	0.00061	CcSEcCtD
Fenofibrate—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000187	0.000606	CcSEcCtD
Fenofibrate—Sweating—Epirubicin—uterine cancer	0.000186	0.000602	CcSEcCtD
Fenofibrate—Pollakiuria—Doxorubicin—uterine cancer	0.000186	0.000602	CcSEcCtD
Fenofibrate—PPARA—Circadian Clock—EP300—uterine cancer	0.000186	0.0101	CbGpPWpGaD
Fenofibrate—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000184	0.000595	CcSEcCtD
Fenofibrate—Hepatobiliary disease—Epirubicin—uterine cancer	0.000183	0.000594	CcSEcCtD
Fenofibrate—Weight increased—Doxorubicin—uterine cancer	0.000183	0.000594	CcSEcCtD
Fenofibrate—Weight decreased—Doxorubicin—uterine cancer	0.000182	0.00059	CcSEcCtD
Fenofibrate—Sinusitis—Epirubicin—uterine cancer	0.000182	0.00059	CcSEcCtD
Fenofibrate—Feeling abnormal—Etoposide—uterine cancer	0.000182	0.000589	CcSEcCtD
Fenofibrate—Nausea—Dactinomycin—uterine cancer	0.000181	0.000587	CcSEcCtD
Fenofibrate—Pneumonia—Doxorubicin—uterine cancer	0.000181	0.000585	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Etoposide—uterine cancer	0.000181	0.000585	CcSEcCtD
Fenofibrate—Infestation NOS—Doxorubicin—uterine cancer	0.00018	0.000581	CcSEcCtD
Fenofibrate—Infestation—Doxorubicin—uterine cancer	0.00018	0.000581	CcSEcCtD
Fenofibrate—Renal failure—Doxorubicin—uterine cancer	0.000176	0.000572	CcSEcCtD
Fenofibrate—Urticaria—Etoposide—uterine cancer	0.000175	0.000568	CcSEcCtD
Fenofibrate—Jaundice—Doxorubicin—uterine cancer	0.000175	0.000567	CcSEcCtD
Fenofibrate—Rhinitis—Epirubicin—uterine cancer	0.000175	0.000566	CcSEcCtD
Fenofibrate—Abdominal pain—Etoposide—uterine cancer	0.000175	0.000565	CcSEcCtD
Fenofibrate—Body temperature increased—Etoposide—uterine cancer	0.000175	0.000565	CcSEcCtD
Fenofibrate—Conjunctivitis—Doxorubicin—uterine cancer	0.000175	0.000565	CcSEcCtD
Fenofibrate—Urinary tract infection—Doxorubicin—uterine cancer	0.000175	0.000565	CcSEcCtD
Fenofibrate—Hepatitis—Epirubicin—uterine cancer	0.000174	0.000564	CcSEcCtD
Fenofibrate—Pharyngitis—Epirubicin—uterine cancer	0.000173	0.00056	CcSEcCtD
Fenofibrate—Sweating—Doxorubicin—uterine cancer	0.000172	0.000557	CcSEcCtD
Fenofibrate—Oedema peripheral—Epirubicin—uterine cancer	0.000172	0.000556	CcSEcCtD
Fenofibrate—Connective tissue disorder—Epirubicin—uterine cancer	0.000171	0.000554	CcSEcCtD
Fenofibrate—CYP2C9—Arachidonic acid metabolism—AKR1C3—uterine cancer	0.00017	0.00927	CbGpPWpGaD
Fenofibrate—Hepatobiliary disease—Doxorubicin—uterine cancer	0.00017	0.00055	CcSEcCtD
Fenofibrate—Sinusitis—Doxorubicin—uterine cancer	0.000168	0.000546	CcSEcCtD
Fenofibrate—Visual impairment—Epirubicin—uterine cancer	0.000168	0.000544	CcSEcCtD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000163	0.00888	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000163	0.00888	CbGpPWpGaD
Fenofibrate—Eye disorder—Epirubicin—uterine cancer	0.000163	0.000527	CcSEcCtD
Fenofibrate—Hypersensitivity—Etoposide—uterine cancer	0.000163	0.000527	CcSEcCtD
Fenofibrate—Cardiac disorder—Epirubicin—uterine cancer	0.000162	0.000524	CcSEcCtD
Fenofibrate—Rhinitis—Doxorubicin—uterine cancer	0.000162	0.000523	CcSEcCtD
Fenofibrate—Hepatitis—Doxorubicin—uterine cancer	0.000161	0.000522	CcSEcCtD
Fenofibrate—Pharyngitis—Doxorubicin—uterine cancer	0.00016	0.000518	CcSEcCtD
Fenofibrate—Oedema peripheral—Doxorubicin—uterine cancer	0.000159	0.000514	CcSEcCtD
Fenofibrate—Asthenia—Etoposide—uterine cancer	0.000158	0.000513	CcSEcCtD
Fenofibrate—Connective tissue disorder—Doxorubicin—uterine cancer	0.000158	0.000513	CcSEcCtD
Fenofibrate—Angiopathy—Epirubicin—uterine cancer	0.000158	0.000512	CcSEcCtD
Fenofibrate—Mediastinal disorder—Epirubicin—uterine cancer	0.000157	0.000508	CcSEcCtD
Fenofibrate—Pruritus—Etoposide—uterine cancer	0.000156	0.000506	CcSEcCtD
Fenofibrate—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000156	0.00848	CbGpPWpGaD
Fenofibrate—Arrhythmia—Epirubicin—uterine cancer	0.000156	0.000504	CcSEcCtD
Fenofibrate—CYP2C8—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000155	0.00845	CbGpPWpGaD
Fenofibrate—Visual impairment—Doxorubicin—uterine cancer	0.000155	0.000503	CcSEcCtD
Fenofibrate—PPARA—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000155	0.00845	CbGpPWpGaD
Fenofibrate—Alopecia—Epirubicin—uterine cancer	0.000154	0.000499	CcSEcCtD
Fenofibrate—CYP2C9—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000154	0.00837	CbGpPWpGaD
Fenofibrate—Mental disorder—Epirubicin—uterine cancer	0.000153	0.000494	CcSEcCtD
Fenofibrate—CYP2C8—renal system—uterine cancer	0.000153	0.0512	CbGeAlD
Fenofibrate—Erythema—Epirubicin—uterine cancer	0.000152	0.000491	CcSEcCtD
Fenofibrate—Malnutrition—Epirubicin—uterine cancer	0.000152	0.000491	CcSEcCtD
Fenofibrate—Diarrhoea—Etoposide—uterine cancer	0.000151	0.000489	CcSEcCtD
Fenofibrate—Eye disorder—Doxorubicin—uterine cancer	0.000151	0.000488	CcSEcCtD
Fenofibrate—Cardiac disorder—Doxorubicin—uterine cancer	0.00015	0.000484	CcSEcCtD
Fenofibrate—Flatulence—Epirubicin—uterine cancer	0.000149	0.000484	CcSEcCtD
Fenofibrate—PPARA—Developmental Biology—HNF1B—uterine cancer	0.000149	0.00811	CbGpPWpGaD
Fenofibrate—Tension—Epirubicin—uterine cancer	0.000149	0.000482	CcSEcCtD
Fenofibrate—CYP2C8—endometrium—uterine cancer	0.000147	0.0495	CbGeAlD
Fenofibrate—Nervousness—Epirubicin—uterine cancer	0.000147	0.000477	CcSEcCtD
Fenofibrate—Back pain—Epirubicin—uterine cancer	0.000147	0.000475	CcSEcCtD
Fenofibrate—CYP2C8—Metapathway biotransformation—AKR1B10—uterine cancer	0.000146	0.00796	CbGpPWpGaD
Fenofibrate—Angiopathy—Doxorubicin—uterine cancer	0.000146	0.000474	CcSEcCtD
Fenofibrate—Dizziness—Etoposide—uterine cancer	0.000146	0.000473	CcSEcCtD
Fenofibrate—Muscle spasms—Epirubicin—uterine cancer	0.000146	0.000472	CcSEcCtD
Fenofibrate—Mediastinal disorder—Doxorubicin—uterine cancer	0.000145	0.00047	CcSEcCtD
Fenofibrate—PPARA—Gene Expression—PHF1—uterine cancer	0.000145	0.0079	CbGpPWpGaD
Fenofibrate—Arrhythmia—Doxorubicin—uterine cancer	0.000144	0.000466	CcSEcCtD
Fenofibrate—Alopecia—Doxorubicin—uterine cancer	0.000142	0.000461	CcSEcCtD
Fenofibrate—PPARA—Transcriptional regulation of white adipocyte differentiation—EP300—uterine cancer	0.000142	0.00772	CbGpPWpGaD
Fenofibrate—Mental disorder—Doxorubicin—uterine cancer	0.000141	0.000457	CcSEcCtD
Fenofibrate—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000141	0.00767	CbGpPWpGaD
Fenofibrate—Ill-defined disorder—Epirubicin—uterine cancer	0.000141	0.000456	CcSEcCtD
Fenofibrate—Vomiting—Etoposide—uterine cancer	0.00014	0.000455	CcSEcCtD
Fenofibrate—Malnutrition—Doxorubicin—uterine cancer	0.00014	0.000454	CcSEcCtD
Fenofibrate—Erythema—Doxorubicin—uterine cancer	0.00014	0.000454	CcSEcCtD
Fenofibrate—Anaemia—Epirubicin—uterine cancer	0.00014	0.000454	CcSEcCtD
Fenofibrate—Rash—Etoposide—uterine cancer	0.000139	0.000451	CcSEcCtD
Fenofibrate—CYP2C8—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000139	0.00757	CbGpPWpGaD
Fenofibrate—Dermatitis—Etoposide—uterine cancer	0.000139	0.00045	CcSEcCtD
Fenofibrate—Headache—Etoposide—uterine cancer	0.000138	0.000448	CcSEcCtD
Fenofibrate—Flatulence—Doxorubicin—uterine cancer	0.000138	0.000448	CcSEcCtD
Fenofibrate—Tension—Doxorubicin—uterine cancer	0.000138	0.000446	CcSEcCtD
Fenofibrate—Malaise—Epirubicin—uterine cancer	0.000137	0.000443	CcSEcCtD
Fenofibrate—Nervousness—Doxorubicin—uterine cancer	0.000136	0.000441	CcSEcCtD
Fenofibrate—Vertigo—Epirubicin—uterine cancer	0.000136	0.000441	CcSEcCtD
Fenofibrate—CYP2C8—Metapathway biotransformation—AKR1B1—uterine cancer	0.000136	0.0074	CbGpPWpGaD
Fenofibrate—Leukopenia—Epirubicin—uterine cancer	0.000136	0.00044	CcSEcCtD
Fenofibrate—Back pain—Doxorubicin—uterine cancer	0.000136	0.00044	CcSEcCtD
Fenofibrate—Muscle spasms—Doxorubicin—uterine cancer	0.000135	0.000437	CcSEcCtD
Fenofibrate—Palpitations—Epirubicin—uterine cancer	0.000134	0.000434	CcSEcCtD
Fenofibrate—Cough—Epirubicin—uterine cancer	0.000132	0.000429	CcSEcCtD
Fenofibrate—Nausea—Etoposide—uterine cancer	0.000131	0.000425	CcSEcCtD
Fenofibrate—Hypertension—Epirubicin—uterine cancer	0.000131	0.000424	CcSEcCtD
Fenofibrate—Ill-defined disorder—Doxorubicin—uterine cancer	0.00013	0.000422	CcSEcCtD
Fenofibrate—Anaemia—Doxorubicin—uterine cancer	0.00013	0.00042	CcSEcCtD
Fenofibrate—Chest pain—Epirubicin—uterine cancer	0.000129	0.000418	CcSEcCtD
Fenofibrate—Myalgia—Epirubicin—uterine cancer	0.000129	0.000418	CcSEcCtD
Fenofibrate—Arthralgia—Epirubicin—uterine cancer	0.000129	0.000418	CcSEcCtD
Fenofibrate—Anxiety—Epirubicin—uterine cancer	0.000129	0.000417	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000128	0.000415	CcSEcCtD
Fenofibrate—Discomfort—Epirubicin—uterine cancer	0.000128	0.000413	CcSEcCtD
Fenofibrate—Malaise—Doxorubicin—uterine cancer	0.000127	0.00041	CcSEcCtD
Fenofibrate—CYP2C9—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000126	0.00688	CbGpPWpGaD
Fenofibrate—Dry mouth—Epirubicin—uterine cancer	0.000126	0.000409	CcSEcCtD
Fenofibrate—Vertigo—Doxorubicin—uterine cancer	0.000126	0.000408	CcSEcCtD
Fenofibrate—Leukopenia—Doxorubicin—uterine cancer	0.000126	0.000407	CcSEcCtD
Fenofibrate—Palpitations—Doxorubicin—uterine cancer	0.000124	0.000402	CcSEcCtD
Fenofibrate—Oedema—Epirubicin—uterine cancer	0.000124	0.000401	CcSEcCtD
Fenofibrate—PPARA—Gene Expression—CHD4—uterine cancer	0.000123	0.00671	CbGpPWpGaD
Fenofibrate—Infection—Epirubicin—uterine cancer	0.000123	0.000398	CcSEcCtD
Fenofibrate—Cough—Doxorubicin—uterine cancer	0.000122	0.000397	CcSEcCtD
Fenofibrate—CYP2C8—female reproductive system—uterine cancer	0.000122	0.041	CbGeAlD
Fenofibrate—Nervous system disorder—Epirubicin—uterine cancer	0.000121	0.000393	CcSEcCtD
Fenofibrate—Thrombocytopenia—Epirubicin—uterine cancer	0.000121	0.000392	CcSEcCtD
Fenofibrate—Hypertension—Doxorubicin—uterine cancer	0.000121	0.000392	CcSEcCtD
Fenofibrate—Tachycardia—Epirubicin—uterine cancer	0.000121	0.000391	CcSEcCtD
Fenofibrate—Skin disorder—Epirubicin—uterine cancer	0.00012	0.000389	CcSEcCtD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.00012	0.00652	CbGpPWpGaD
Fenofibrate—Hyperhidrosis—Epirubicin—uterine cancer	0.00012	0.000387	CcSEcCtD
Fenofibrate—Chest pain—Doxorubicin—uterine cancer	0.000119	0.000387	CcSEcCtD
Fenofibrate—Arthralgia—Doxorubicin—uterine cancer	0.000119	0.000387	CcSEcCtD
Fenofibrate—Myalgia—Doxorubicin—uterine cancer	0.000119	0.000387	CcSEcCtD
Fenofibrate—CYP2C9—Metapathway biotransformation—AKR1B10—uterine cancer	0.000119	0.00648	CbGpPWpGaD
Fenofibrate—Anxiety—Doxorubicin—uterine cancer	0.000119	0.000386	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000119	0.000384	CcSEcCtD
Fenofibrate—Discomfort—Doxorubicin—uterine cancer	0.000118	0.000382	CcSEcCtD
Fenofibrate—Anorexia—Epirubicin—uterine cancer	0.000118	0.000382	CcSEcCtD
Fenofibrate—Dry mouth—Doxorubicin—uterine cancer	0.000117	0.000378	CcSEcCtD
Fenofibrate—Hypotension—Epirubicin—uterine cancer	0.000116	0.000375	CcSEcCtD
Fenofibrate—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000115	0.00624	CbGpPWpGaD
Fenofibrate—Oedema—Doxorubicin—uterine cancer	0.000114	0.000371	CcSEcCtD
Fenofibrate—CYP2C8—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000114	0.00622	CbGpPWpGaD
Fenofibrate—Infection—Doxorubicin—uterine cancer	0.000114	0.000368	CcSEcCtD
Fenofibrate—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000113	0.00616	CbGpPWpGaD
Fenofibrate—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000113	0.000365	CcSEcCtD
Fenofibrate—Nervous system disorder—Doxorubicin—uterine cancer	0.000112	0.000364	CcSEcCtD
Fenofibrate—Thrombocytopenia—Doxorubicin—uterine cancer	0.000112	0.000363	CcSEcCtD
Fenofibrate—Insomnia—Epirubicin—uterine cancer	0.000112	0.000363	CcSEcCtD
Fenofibrate—Tachycardia—Doxorubicin—uterine cancer	0.000112	0.000362	CcSEcCtD
Fenofibrate—Skin disorder—Doxorubicin—uterine cancer	0.000111	0.00036	CcSEcCtD
Fenofibrate—Paraesthesia—Epirubicin—uterine cancer	0.000111	0.00036	CcSEcCtD
Fenofibrate—Hyperhidrosis—Doxorubicin—uterine cancer	0.000111	0.000359	CcSEcCtD
Fenofibrate—CYP2C9—Metapathway biotransformation—AKR1B1—uterine cancer	0.000111	0.00602	CbGpPWpGaD
Fenofibrate—CYP2C8—vagina—uterine cancer	0.00011	0.0371	CbGeAlD
Fenofibrate—Dyspnoea—Epirubicin—uterine cancer	0.00011	0.000357	CcSEcCtD
Fenofibrate—Somnolence—Epirubicin—uterine cancer	0.00011	0.000356	CcSEcCtD
Fenofibrate—Anorexia—Doxorubicin—uterine cancer	0.000109	0.000354	CcSEcCtD
Fenofibrate—Dyspepsia—Epirubicin—uterine cancer	0.000109	0.000353	CcSEcCtD
Fenofibrate—CYP2C9—female reproductive system—uterine cancer	0.000109	0.0364	CbGeAlD
Fenofibrate—Decreased appetite—Epirubicin—uterine cancer	0.000108	0.000348	CcSEcCtD
Fenofibrate—Hypotension—Doxorubicin—uterine cancer	0.000107	0.000347	CcSEcCtD
Fenofibrate—PPARA—Generic Transcription Pathway—PGR—uterine cancer	0.000107	0.00582	CbGpPWpGaD
Fenofibrate—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000107	0.000346	CcSEcCtD
Fenofibrate—PPARA—PPARA activates gene expression—EP300—uterine cancer	0.000107	0.00581	CbGpPWpGaD
Fenofibrate—Fatigue—Epirubicin—uterine cancer	0.000107	0.000346	CcSEcCtD
Fenofibrate—Pain—Epirubicin—uterine cancer	0.000106	0.000343	CcSEcCtD
Fenofibrate—Constipation—Epirubicin—uterine cancer	0.000106	0.000343	CcSEcCtD
Fenofibrate—PPARA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—uterine cancer	0.000104	0.00568	CbGpPWpGaD
Fenofibrate—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000104	0.000338	CcSEcCtD
Fenofibrate—Insomnia—Doxorubicin—uterine cancer	0.000104	0.000335	CcSEcCtD
Fenofibrate—PPARA—Gene Expression—SUZ12—uterine cancer	0.000103	0.00563	CbGpPWpGaD
Fenofibrate—CYP3A4—renal system—uterine cancer	0.000103	0.0347	CbGeAlD
Fenofibrate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000103	0.00559	CbGpPWpGaD
Fenofibrate—Paraesthesia—Doxorubicin—uterine cancer	0.000103	0.000333	CcSEcCtD
Fenofibrate—Dyspnoea—Doxorubicin—uterine cancer	0.000102	0.000331	CcSEcCtD
Fenofibrate—Feeling abnormal—Epirubicin—uterine cancer	0.000102	0.00033	CcSEcCtD
Fenofibrate—Somnolence—Doxorubicin—uterine cancer	0.000102	0.00033	CcSEcCtD
Fenofibrate—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000101	0.00552	CbGpPWpGaD
Fenofibrate—Gastrointestinal pain—Epirubicin—uterine cancer	0.000101	0.000328	CcSEcCtD
Fenofibrate—Dyspepsia—Doxorubicin—uterine cancer	0.000101	0.000326	CcSEcCtD
Fenofibrate—PPARA—Metabolism—NDUFB11—uterine cancer	0.000101	0.00547	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—SRD5A2—uterine cancer	0.000101	0.00547	CbGpPWpGaD
Fenofibrate—PPARA—Adipogenesis—CTNNB1—uterine cancer	0.0001	0.00546	CbGpPWpGaD
Fenofibrate—CYP2C8—Metapathway biotransformation—AKR1C1—uterine cancer	9.98e-05	0.00543	CbGpPWpGaD
Fenofibrate—Decreased appetite—Doxorubicin—uterine cancer	9.95e-05	0.000322	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Doxorubicin—uterine cancer	9.89e-05	0.00032	CcSEcCtD
Fenofibrate—Fatigue—Doxorubicin—uterine cancer	9.87e-05	0.00032	CcSEcCtD
Fenofibrate—Urticaria—Epirubicin—uterine cancer	9.83e-05	0.000318	CcSEcCtD
Fenofibrate—Pain—Doxorubicin—uterine cancer	9.79e-05	0.000317	CcSEcCtD
Fenofibrate—Constipation—Doxorubicin—uterine cancer	9.79e-05	0.000317	CcSEcCtD
Fenofibrate—Body temperature increased—Epirubicin—uterine cancer	9.78e-05	0.000317	CcSEcCtD
Fenofibrate—Abdominal pain—Epirubicin—uterine cancer	9.78e-05	0.000317	CcSEcCtD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	9.77e-05	0.00531	CbGpPWpGaD
Fenofibrate—Feeling abnormal—Doxorubicin—uterine cancer	9.44e-05	0.000306	CcSEcCtD
Fenofibrate—PPARA—Generic Transcription Pathway—ESR2—uterine cancer	9.42e-05	0.00512	CbGpPWpGaD
Fenofibrate—Gastrointestinal pain—Doxorubicin—uterine cancer	9.36e-05	0.000303	CcSEcCtD
Fenofibrate—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	9.36e-05	0.00509	CbGpPWpGaD
Fenofibrate—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	9.3e-05	0.00506	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	9.23e-05	0.00502	CbGpPWpGaD
Fenofibrate—Hypersensitivity—Epirubicin—uterine cancer	9.12e-05	0.000295	CcSEcCtD
Fenofibrate—Urticaria—Doxorubicin—uterine cancer	9.1e-05	0.000295	CcSEcCtD
Fenofibrate—Abdominal pain—Doxorubicin—uterine cancer	9.05e-05	0.000293	CcSEcCtD
Fenofibrate—Body temperature increased—Doxorubicin—uterine cancer	9.05e-05	0.000293	CcSEcCtD
Fenofibrate—Asthenia—Epirubicin—uterine cancer	8.88e-05	0.000288	CcSEcCtD
Fenofibrate—CYP2C8—Metapathway biotransformation—GPX3—uterine cancer	8.76e-05	0.00477	CbGpPWpGaD
Fenofibrate—Pruritus—Epirubicin—uterine cancer	8.75e-05	0.000284	CcSEcCtD
Fenofibrate—Diarrhoea—Epirubicin—uterine cancer	8.47e-05	0.000274	CcSEcCtD
Fenofibrate—Hypersensitivity—Doxorubicin—uterine cancer	8.44e-05	0.000273	CcSEcCtD
Fenofibrate—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	8.34e-05	0.00454	CbGpPWpGaD
Fenofibrate—CYP3A4—female reproductive system—uterine cancer	8.27e-05	0.0278	CbGeAlD
Fenofibrate—CYP2C8—Biological oxidations—CYP11A1—uterine cancer	8.25e-05	0.00449	CbGpPWpGaD
Fenofibrate—Asthenia—Doxorubicin—uterine cancer	8.21e-05	0.000266	CcSEcCtD
Fenofibrate—Dizziness—Epirubicin—uterine cancer	8.18e-05	0.000265	CcSEcCtD
Fenofibrate—CYP2C8—Metapathway biotransformation—CYP11A1—uterine cancer	8.14e-05	0.00443	CbGpPWpGaD
Fenofibrate—CYP2C9—Metapathway biotransformation—AKR1C1—uterine cancer	8.12e-05	0.00442	CbGpPWpGaD
Fenofibrate—Pruritus—Doxorubicin—uterine cancer	8.1e-05	0.000262	CcSEcCtD
Fenofibrate—Vomiting—Epirubicin—uterine cancer	7.87e-05	0.000255	CcSEcCtD
Fenofibrate—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	7.85e-05	0.00427	CbGpPWpGaD
Fenofibrate—Diarrhoea—Doxorubicin—uterine cancer	7.83e-05	0.000254	CcSEcCtD
Fenofibrate—Rash—Epirubicin—uterine cancer	7.8e-05	0.000253	CcSEcCtD
Fenofibrate—Dermatitis—Epirubicin—uterine cancer	7.8e-05	0.000252	CcSEcCtD
Fenofibrate—Headache—Epirubicin—uterine cancer	7.75e-05	0.000251	CcSEcCtD
Fenofibrate—CYP2C8—Metapathway biotransformation—AKR1C3—uterine cancer	7.68e-05	0.00418	CbGpPWpGaD
Fenofibrate—PPARA—Generic Transcription Pathway—CDKN2B—uterine cancer	7.67e-05	0.00417	CbGpPWpGaD
Fenofibrate—Dizziness—Doxorubicin—uterine cancer	7.57e-05	0.000245	CcSEcCtD
Fenofibrate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	7.57e-05	0.00412	CbGpPWpGaD
Fenofibrate—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	7.47e-05	0.00406	CbGpPWpGaD
Fenofibrate—Nausea—Epirubicin—uterine cancer	7.35e-05	0.000238	CcSEcCtD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	7.32e-05	0.00398	CbGpPWpGaD
Fenofibrate—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	7.3e-05	0.00397	CbGpPWpGaD
Fenofibrate—Vomiting—Doxorubicin—uterine cancer	7.28e-05	0.000236	CcSEcCtD
Fenofibrate—PPARA—Metabolism—STAR—uterine cancer	7.27e-05	0.00396	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—AKR1B1—uterine cancer	7.27e-05	0.00396	CbGpPWpGaD
Fenofibrate—Rash—Doxorubicin—uterine cancer	7.22e-05	0.000234	CcSEcCtD
Fenofibrate—Dermatitis—Doxorubicin—uterine cancer	7.21e-05	0.000234	CcSEcCtD
Fenofibrate—PPARA—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	7.2e-05	0.00391	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	7.19e-05	0.00391	CbGpPWpGaD
Fenofibrate—Headache—Doxorubicin—uterine cancer	7.17e-05	0.000232	CcSEcCtD
Fenofibrate—CYP2C9—Metapathway biotransformation—GPX3—uterine cancer	7.13e-05	0.00388	CbGpPWpGaD
Fenofibrate—PPARA—Generic Transcription Pathway—SMAD3—uterine cancer	7e-05	0.00381	CbGpPWpGaD
Fenofibrate—PPARA—Circadian rythm related genes—PTEN—uterine cancer	6.91e-05	0.00376	CbGpPWpGaD
Fenofibrate—Nausea—Doxorubicin—uterine cancer	6.8e-05	0.00022	CcSEcCtD
Fenofibrate—CYP2C9—Biological oxidations—CYP11A1—uterine cancer	6.72e-05	0.00365	CbGpPWpGaD
Fenofibrate—CYP2C9—Metapathway biotransformation—CYP11A1—uterine cancer	6.62e-05	0.0036	CbGpPWpGaD
Fenofibrate—PPARA—Circadian rythm related genes—EP300—uterine cancer	6.59e-05	0.00358	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—SMAD3—uterine cancer	6.59e-05	0.00358	CbGpPWpGaD
Fenofibrate—CYP2C9—Metapathway biotransformation—AKR1C3—uterine cancer	6.25e-05	0.0034	CbGpPWpGaD
Fenofibrate—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	6.13e-05	0.00334	CbGpPWpGaD
Fenofibrate—CYP2C8—Biological oxidations—CYP19A1—uterine cancer	6.07e-05	0.0033	CbGpPWpGaD
Fenofibrate—CYP2C8—Metapathway biotransformation—CYP19A1—uterine cancer	5.99e-05	0.00326	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	5.96e-05	0.00324	CbGpPWpGaD
Fenofibrate—PPARA—Generic Transcription Pathway—ESR1—uterine cancer	5.71e-05	0.00311	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—POLD1—uterine cancer	5.71e-05	0.0031	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—MET—uterine cancer	5.4e-05	0.00294	CbGpPWpGaD
Fenofibrate—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	5.36e-05	0.00291	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—AKR1C1—uterine cancer	5.34e-05	0.0029	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—STAR—uterine cancer	5.3e-05	0.00288	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	5.3e-05	0.00288	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—PGR—uterine cancer	5.15e-05	0.0028	CbGpPWpGaD
Fenofibrate—CYP2C9—Biological oxidations—CYP19A1—uterine cancer	4.94e-05	0.00269	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—EZH2—uterine cancer	4.89e-05	0.00266	CbGpPWpGaD
Fenofibrate—CYP2C9—Metapathway biotransformation—CYP19A1—uterine cancer	4.87e-05	0.00265	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—RRM2—uterine cancer	4.76e-05	0.00259	CbGpPWpGaD
Fenofibrate—PPARA—Circadian rythm related genes—TP53—uterine cancer	4.71e-05	0.00256	CbGpPWpGaD
Fenofibrate—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	4.7e-05	0.00256	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—DCN—uterine cancer	4.62e-05	0.00251	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—ESR2—uterine cancer	4.53e-05	0.00247	CbGpPWpGaD
Fenofibrate—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	4.43e-05	0.00241	CbGpPWpGaD
Fenofibrate—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	4.37e-05	0.00238	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—CYP11A1—uterine cancer	4.35e-05	0.00237	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	4.31e-05	0.00234	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	4.31e-05	0.00234	CbGpPWpGaD
Fenofibrate—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	4.12e-05	0.00224	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—AKR1C3—uterine cancer	4.11e-05	0.00224	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—ERBB2—uterine cancer	3.95e-05	0.00215	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.89e-05	0.00211	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—CDKN2B—uterine cancer	3.69e-05	0.00201	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—CTNNB1—uterine cancer	3.45e-05	0.00188	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—SMAD3—uterine cancer	3.37e-05	0.00183	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—SRD5A2—uterine cancer	3.26e-05	0.00177	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—NDUFB11—uterine cancer	3.26e-05	0.00177	CbGpPWpGaD
Fenofibrate—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	3.26e-05	0.00177	CbGpPWpGaD
Fenofibrate—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	3.21e-05	0.00175	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—EP300—uterine cancer	3.21e-05	0.00175	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—STK11—uterine cancer	3.2e-05	0.00174	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—CYP19A1—uterine cancer	3.2e-05	0.00174	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.17e-05	0.00172	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.16e-05	0.00172	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—VEGFA—uterine cancer	3.04e-05	0.00165	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.01e-05	0.00163	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—NRAS—uterine cancer	3e-05	0.00163	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.99e-05	0.00163	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.87e-05	0.00156	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—ESR1—uterine cancer	2.75e-05	0.0015	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—SRD5A2—uterine cancer	2.65e-05	0.00144	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—NDUFB11—uterine cancer	2.65e-05	0.00144	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—KRAS—uterine cancer	2.58e-05	0.00141	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.58e-05	0.0014	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.44e-05	0.00132	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—MTHFR—uterine cancer	2.41e-05	0.00131	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—STAR—uterine cancer	2.36e-05	0.00128	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—AKR1B1—uterine cancer	2.36e-05	0.00128	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.33e-05	0.00127	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—HRAS—uterine cancer	2.2e-05	0.00119	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.12e-05	0.00115	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—AKT1—uterine cancer	1.94e-05	0.00105	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—STAR—uterine cancer	1.92e-05	0.00104	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—AKR1B1—uterine cancer	1.92e-05	0.00104	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.9e-05	0.00103	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—POLD1—uterine cancer	1.85e-05	0.00101	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.75e-05	0.000952	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.75e-05	0.000952	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—AKR1C1—uterine cancer	1.73e-05	0.000942	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—RRM2—uterine cancer	1.54e-05	0.000839	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—POLD1—uterine cancer	1.51e-05	0.000819	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—DCN—uterine cancer	1.5e-05	0.000815	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CYP11A1—uterine cancer	1.41e-05	0.000768	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—AKR1C1—uterine cancer	1.41e-05	0.000766	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—PTEN—uterine cancer	1.34e-05	0.000728	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—AKR1C3—uterine cancer	1.33e-05	0.000725	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—EP300—uterine cancer	1.28e-05	0.000694	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—STAR—uterine cancer	1.27e-05	0.000689	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.27e-05	0.000689	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—RRM2—uterine cancer	1.26e-05	0.000683	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—DCN—uterine cancer	1.22e-05	0.000663	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CYP11A1—uterine cancer	1.15e-05	0.000625	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—AKR1C3—uterine cancer	1.08e-05	0.00059	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—STK11—uterine cancer	1.04e-05	0.000565	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CYP19A1—uterine cancer	1.04e-05	0.000565	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—POLD1—uterine cancer	9.93e-06	0.00054	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—AKT1—uterine cancer	9.92e-06	0.00054	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	9.74e-06	0.00053	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—PIK3CA—uterine cancer	9.44e-06	0.000514	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	9.29e-06	0.000506	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—AKR1C1—uterine cancer	9.29e-06	0.000505	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CYP19A1—uterine cancer	8.45e-06	0.00046	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—STK11—uterine cancer	8.45e-06	0.00046	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—RRM2—uterine cancer	8.28e-06	0.00045	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—DCN—uterine cancer	8.04e-06	0.000437	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.93e-06	0.000431	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—MTHFR—uterine cancer	7.8e-06	0.000424	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—AKT1—uterine cancer	7.71e-06	0.00042	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CYP11A1—uterine cancer	7.57e-06	0.000412	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.56e-06	0.000411	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—AKR1C3—uterine cancer	7.15e-06	0.000389	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.87e-06	0.000374	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—MTHFR—uterine cancer	6.35e-06	0.000345	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.59e-06	0.000304	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—STK11—uterine cancer	5.57e-06	0.000303	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CYP19A1—uterine cancer	5.57e-06	0.000303	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PTEN—uterine cancer	4.34e-06	0.000236	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—MTHFR—uterine cancer	4.19e-06	0.000228	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—EP300—uterine cancer	4.14e-06	0.000225	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PTEN—uterine cancer	3.53e-06	0.000192	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—EP300—uterine cancer	3.37e-06	0.000183	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PIK3CA—uterine cancer	3.06e-06	0.000167	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—AKT1—uterine cancer	2.5e-06	0.000136	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PIK3CA—uterine cancer	2.49e-06	0.000136	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PTEN—uterine cancer	2.33e-06	0.000127	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—EP300—uterine cancer	2.22e-06	0.000121	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—AKT1—uterine cancer	2.04e-06	0.000111	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.64e-06	8.94e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—AKT1—uterine cancer	1.34e-06	7.3e-05	CbGpPWpGaD
